0001396814-24-000017.txt : 20240207
0001396814-24-000017.hdr.sgml : 20240207
20240207165939
ACCESSION NUMBER: 0001396814-24-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GAUGLER DARYL
CENTRAL INDEX KEY: 0001928278
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35060
FILM NUMBER: 24605067
MAIL ADDRESS:
STREET 1: C/O PACIRA BIOSCIENCES, INC.
STREET 2: 5401 WEST KENNEDY BOULEVARD, SUITE 890
CITY: TAMPA
STATE: FL
ZIP: 33609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pacira BioSciences, Inc.
CENTRAL INDEX KEY: 0001396814
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 510619477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5401 WEST KENNEDY BOULEVARD
STREET 2: SUITE 890
CITY: TAMPA
STATE: FL
ZIP: 33609
BUSINESS PHONE: 813-553-6680
MAIL ADDRESS:
STREET 1: 5401 WEST KENNEDY BOULEVARD
STREET 2: SUITE 890
CITY: TAMPA
STATE: FL
ZIP: 33609
FORMER COMPANY:
FORMER CONFORMED NAME: Pacira Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20101029
FORMER COMPANY:
FORMER CONFORMED NAME: PACIRA INC
DATE OF NAME CHANGE: 20080318
FORMER COMPANY:
FORMER CONFORMED NAME: Blue Acquisition Corp
DATE OF NAME CHANGE: 20070418
4
1
wk-form4_1707343168.xml
FORM 4
X0508
4
2024-02-05
0
0001396814
Pacira BioSciences, Inc.
PCRX
0001928278
GAUGLER DARYL
C/O PACIRA BIOSCIENCES, INC.
5401 WEST KENNEDY BOULEVARD, SUITE 890
TAMPA
FL
33609
0
1
0
0
Chief Operating Officer
0
Common Stock
2024-02-05
4
A
0
33700
0
A
65493.584
D
Represents restricted stock units that vest on February 1, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Includes 135.988 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023.
/s/ Kristen Williams, Attorney-in-Fact
2024-02-07